IL17A and myeloid sarcoma: It is important that in MS patients, the effect of original and generic GA on IL-17 production by stimulated PBMCs was comparable (Fig 1A) while in healthy subjects the inhibitory effect of generic GA (at a concentration of 200 μg/ml) on IL-17 production was significantly higher than effect of original GA (Fig 1B).